Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

A rebalancing of gold's ratios versus major commodities
July 14, 2026 / www.canadianminingreport.com

Gold stocks down on slide in gold price
July 14, 2026 / www.canadianminingreport.com

US tariff decision expected to be major copper catalyst
July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows
July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops
June 29, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok